IOT

415 Capital is a specialist venture capital firm dedicated to investing in breakthrough and life-saving medical innovation. For over 30 years, the team has empowered exceptional entrepreneurs through capital, expertise, and market access, focusing on large unmet patient needs in chronic diseases, particularly cardio & neurovascular disorders.

The corporate venture arm of AbbVie, investing in novel, transformational therapeutics at discovery and preclinical stages.

Abstract is a venture capital firm based in San Francisco with $1.5 billion in assets under management. They are sector-agnostic and invest in seed and early-stage companies. Their focus is on fierce loyalty, unparalleled connections, and helping founders win.

Accord Ventures is a venture capital fund that believes in the potential of Asia and the power of diversity. They focus mainly on IT-enabled platform businesses and support value-added technology companies in various sectors. The partners leverage their experience in early-stage startups and listed companies to support entrepreneurs.

Allegion Ventures invests in and accelerates the growth of companies with innovative technology and software to bridge physical and digital security and create seamless user experiences.

Altitude Life Science Ventures is a venture capital firm investing in early-stage life science companies. They focus on markets with strong demand and growth potential, and then back the highest-quality entrepreneurs.

Alumni Ventures is a network-powered venture capital firm providing access to professionally-managed, diversified venture portfolios for accredited investors and institutions. Its large and well-connected network fuels deal flow and value-added services to portfolio companies.

Andreessen Horowitz (a16z) is a venture capital firm with $45B in committed capital, founded by Marc Andreessen and Ben Horowitz. A16z invests in technology startups and entrepreneurs across multiple stages and various industries. They are stage agnostic and invest in companies building the future through technology.

Artiman is an early stage sector agnostic venture fund.

Artis Ventures is a venture capital firm focused on investments at the convergence of frontier technologies and medicine. They invest in data-driven life sciences companies creating scalable medical technologies with broad healthcare applications. Their focus is on creating global impact through engineering-first approaches and flexible investment strategies.

Atlas Venture builds breakthrough biotechnology companies, partnering with leading life science entrepreneurs to translate groundbreaking science into life-changing medicines. With over 30 years of experience, they have a strong track record of launching startups and achieving successful exits.

ATX Venture Partners is an early-stage venture capital firm investing across North America, primarily in disruptive B2B software, APIs, marketplaces, and applications. They focus on providing capital and a value-add platform to help portfolio companies accelerate growth.